Wave Life Sciences, Inc. SEC filings WVE
Wave Life Sciences, Inc. has 743 filings in SEC EDGAR's recent list, going back to Feb 2, 2015. Its latest annual report, Form ARS, was filed on Oct 14, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Oct 27, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Oct 27, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| SCHEDULE 13G | Ownership over 5% (passive) | Oct 27, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Oct 27, 2026 | — |
| 10-Q | Quarterly report | Oct 27, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Oct 27, 2026 | Oct 27, 2026 |
| ARS | Annual report to shareholders | Oct 14, 2026 | Dec 31, 2025 |
| DEF 14A | Proxy statement | Oct 14, 2026 | Nov 12, 2026 |
| 4 | Insider transaction | Oct 7, 2026 | Oct 5, 2026 |
| 4 | Insider transaction | Oct 7, 2026 | Oct 5, 2026 |
| 4 | Insider transaction | Oct 7, 2026 | Oct 5, 2026 |
| 4 | Insider transaction | Oct 7, 2026 | Oct 5, 2026 |
| 4 | Insider transaction | Oct 7, 2026 | Oct 5, 2026 |
| 4 | Insider transaction | Oct 7, 2026 | Oct 5, 2026 |
| 4 | Insider transaction | Oct 7, 2026 | Oct 5, 2026 |
| 4 | Insider transaction | Oct 7, 2026 | Oct 5, 2026 |
| EFFECT | Filing | Aug 14, 2026 | — |
| 4 | Insider transaction | Aug 13, 2026 | Aug 11, 2026 |
| 4 | Insider transaction | Aug 13, 2026 | Aug 12, 2026 |
| 4 | Insider transaction | Aug 13, 2026 | Aug 11, 2026 |
| 4 | Insider transaction | Aug 13, 2026 | Aug 11, 2026 |
| 144 | Notice of proposed sale | Aug 12, 2026 | — |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Aug 11, 2026 | — |
| 144 | Notice of proposed sale | Aug 11, 2026 | — |
| 15-12G | Deregistration | Aug 10, 2026 | — |
| POS AM | Filing | Aug 10, 2026 | — |
| POSASR | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| S-8 POS | Filing | Aug 10, 2026 | — |
| 8-K12B | Filing | Aug 7, 2026 | Aug 7, 2026 |
| 10-Q | Quarterly report | Jul 30, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jul 30, 2026 | Jul 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 26, 2026 | Jun 22, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
May 18, 2026 | May 18, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 13, 2026 | — |
| DEF 14A | Proxy statement | May 7, 2026 | Jun 22, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 6, 2026 | — |
| UPLOAD | Letter from the SEC | May 5, 2026 | — |
| CORRESP | Letter to the SEC | May 1, 2026 | — |
| PRER14A | Filing | May 1, 2026 | — |
| 10-K/A | Amended annual report | Apr 30, 2026 | Dec 31, 2025 |
| UPLOAD | Letter from the SEC | Apr 30, 2026 | — |
| 10-Q | Quarterly report | Apr 28, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Apr 28, 2026 | Apr 28, 2026 |
| DEFA14A | Additional proxy material | Apr 21, 2026 | — |
| 8-K |
Current report
Other events
|
Apr 21, 2026 | Apr 21, 2026 |
| 3 | Initial insider ownership | Apr 17, 2026 | Apr 9, 2026 |
| 3 | Initial insider ownership | Apr 17, 2026 | Apr 9, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Apr 17, 2026 | — |
| PRE 14A | Preliminary proxy statement | Apr 15, 2026 | Apr 15, 2026 |
| DEFA14A | Additional proxy material | Apr 15, 2026 | — |
| 8-K |
Current report
Material agreement, Other events
|
Apr 15, 2026 | Apr 15, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Mar 30, 2026 | — |
| 4 | Insider transaction | Mar 30, 2026 | Mar 26, 2026 |
| 4 | Insider transaction | Mar 26, 2026 | Mar 23, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 26, 2026 | Mar 26, 2026 |
| 4 | Insider transaction | Feb 27, 2026 | Feb 26, 2026 |
| 10-K | Annual report | Feb 26, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 26, 2026 | Feb 26, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2026 | — |
| 4 | Insider transaction | Feb 11, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 5, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 5, 2026 |
| 144 | Notice of proposed sale | Feb 9, 2026 | — |
| 144 | Notice of proposed sale | Feb 9, 2026 | — |
| 144 | Notice of proposed sale | Feb 9, 2026 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Feb 5, 2026 | — |
| 8-K |
Current report
Other events
|
Feb 2, 2026 | Feb 2, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Jan 2, 2026 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Dec 15, 2025 | — |
| 4 | Insider transaction | Dec 15, 2025 | Dec 11, 2025 |
| 424B5 | Prospectus supplement | Dec 11, 2025 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Dec 11, 2025 | Dec 9, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 8, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 8, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 8, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 8, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 8, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 8, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 8, 2025 |
| 4 | Insider transaction | Dec 10, 2025 | Dec 8, 2025 |
| 144 | Notice of proposed sale | Dec 9, 2025 | — |
| 144 | Notice of proposed sale | Dec 8, 2025 | — |
| 424B5 | Prospectus supplement | Dec 8, 2025 | — |
| 144 | Notice of proposed sale | Dec 8, 2025 | — |
| 144 | Notice of proposed sale | Dec 8, 2025 | — |
| 144 | Notice of proposed sale | Dec 8, 2025 | — |
| 144 | Notice of proposed sale | Dec 8, 2025 | — |
| 144 | Notice of proposed sale | Dec 8, 2025 | — |
| 144 | Notice of proposed sale | Dec 8, 2025 | — |
| 144 | Notice of proposed sale | Dec 8, 2025 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Dec 8, 2025 | Dec 8, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 17, 2025 | Nov 17, 2025 |
| 4 | Insider transaction | Nov 14, 2025 | Nov 13, 2025 |
| 4 | Insider transaction | Nov 14, 2025 | Nov 13, 2025 |
| SCHEDULE 13D/A | Amended ownership over 5% (active) | Nov 13, 2025 | — |
| 144 | Notice of proposed sale | Nov 13, 2025 | — |
| S-8 | Employee stock plan registration | Nov 10, 2025 | — |
| S-8 | Employee stock plan registration | Nov 10, 2025 | — |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K/A |
Amended current report
Regulation FD disclosure, Other events
|
Oct 30, 2025 | Oct 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 29, 2025 | Oct 29, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 24, 2025 | Sep 24, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 3, 2025 | Sep 3, 2025 |
| 4 | Insider transaction | Aug 26, 2025 | Aug 22, 2025 |
| 4 | Insider transaction | Aug 26, 2025 | Aug 22, 2025 |
| 144 | Notice of proposed sale | Aug 22, 2025 | — |
| 144 | Notice of proposed sale | Aug 22, 2025 | — |
| 4 | Insider transaction | Aug 19, 2025 | Aug 15, 2025 |
| 144 | Notice of proposed sale | Aug 15, 2025 | — |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| 144 | Notice of proposed sale | Aug 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 12, 2025 | — |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 11, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Aug 7, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Aug 7, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 5, 2025 | Aug 5, 2025 |
| 10-Q | Quarterly report | Jul 30, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Jul 30, 2025 | Jul 30, 2025 |
| ARS | Annual report to shareholders | Jun 23, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Jun 23, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Jun 13, 2025 | Jun 13, 2025 |
| 144 | Notice of proposed sale | Jun 13, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 12, 2025 | — |
| 10-Q | Quarterly report | May 8, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 8, 2025 | May 8, 2025 |
| 10-K/A | Amended annual report | Apr 29, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 26, 2025 | Mar 26, 2025 |
| 4 | Insider transaction | Mar 21, 2025 | Mar 20, 2025 |
| 144 | Notice of proposed sale | Mar 20, 2025 | — |
| 4 | Insider transaction | Mar 7, 2025 | Mar 7, 2025 |
| 4 | Insider transaction | Mar 7, 2025 | Mar 5, 2025 |
| 144 | Notice of proposed sale | Mar 7, 2025 | — |
| 4 | Insider transaction | Mar 5, 2025 | Mar 4, 2025 |
| 10-K | Annual report | Mar 4, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 4, 2025 | Mar 4, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| 4 | Insider transaction | Feb 6, 2025 | Feb 4, 2025 |
| 4 | Insider transaction | Feb 6, 2025 | Feb 4, 2025 |
| 4 | Insider transaction | Feb 6, 2025 | Feb 4, 2025 |
| 4 | Insider transaction | Feb 6, 2025 | Feb 4, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2025 | — |
| 4 | Insider transaction | Jan 24, 2025 | Jan 23, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Nov 27, 2024 | Nov 25, 2024 |
| 144 | Notice of proposed sale | Nov 25, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 20, 2024 | Nov 20, 2024 |
| 4 | Insider transaction | Nov 15, 2024 | Nov 15, 2024 |
| 144 | Notice of proposed sale | Nov 15, 2024 | — |
| 4 | Insider transaction | Nov 13, 2024 | Nov 8, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| S-8 | Employee stock plan registration | Nov 12, 2024 | — |
| S-8 | Employee stock plan registration | Nov 12, 2024 | — |
| S-3ASR | Automatic shelf registration | Nov 12, 2024 | — |
| 10-Q | Quarterly report | Nov 12, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2024 | Nov 12, 2024 |
| 144 | Notice of proposed sale | Nov 8, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 30, 2024 | Oct 30, 2024 |
| 4 | Insider transaction | Oct 18, 2024 | Oct 16, 2024 |
| 4 | Insider transaction | Oct 18, 2024 | Oct 16, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 18, 2024 | — |
| 144 | Notice of proposed sale | Oct 16, 2024 | — |
| 144 | Notice of proposed sale | Oct 16, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 16, 2024 | Oct 16, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 15, 2024 | Oct 11, 2024 |
| 4 | Insider transaction | Oct 11, 2024 | Oct 11, 2024 |
| 4 | Insider transaction | Oct 1, 2024 | Sep 27, 2024 |
| SC 13D/A | Amended ownership over 5% (active) | Oct 1, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 1, 2024 | Oct 1, 2024 |
| 4 | Insider transaction | Sep 27, 2024 | Sep 25, 2024 |
| 424B5 | Prospectus supplement | Sep 27, 2024 | — |
| 8-K |
Current report
Material agreement, Regulation FD disclosure, Other events
|
Sep 26, 2024 | Sep 25, 2024 |
| 144 | Notice of proposed sale | Sep 25, 2024 | — |
| 424B5 | Prospectus supplement | Sep 24, 2024 | — |
| 424B3 | Prospectus | Sep 24, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Sep 24, 2024 | Sep 24, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- WVE (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Cambridge, MA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1631574
- Former names
- Wave Life Sciences Ltd. (until Jul 30, 2026); Wave Life Sciences LTD. (until Jul 30, 2026); WAVE Life Sciences Ltd. (until Jul 30, 2026); Wave Life Sciences Pte Ltd (until Nov 2, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.